{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T23:47:48Z","timestamp":1788220068982,"version":"build-2803163510"},"reference-count":91,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Metab"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Untargeted metabolomics has emerged as a powerful approach to uncover metabolic dysregulation associated with cancer progression. When integrated with a machine learning strategy it facilitates the discovery of key metabolic pathways and predictive biomarkers with high diagnostic and prognostic value.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this study, we employed liquid chromatography coupled to high-resolution Tribrid Orbitrap mass spectrometry to perform comprehensive metabolic profiling of bladder cancer (BLCA) as well as predict invasiveness of the disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>By leveraging both in-house retention time-based MS\/MS spectral libraries and commercial databases, we robustly identify over 2000 metabolites. In addition, this platform allows identification of novel pathways highlighting metabolic vulnerabilities in BLCA. The application of machine learning algorithms and advanced computational modeling uncovered metabolic signatures that differentiate BLCA from adjacent normal\/benign samples and distinguish muscle-invasive from non-muscle-invasive bladder cancer. Our integrative analytical pipeline addresses key challenges in metabolomics-including high dimensionality, metabolite annotation, and biological variability-through feature selection and predictive modeling. We identify candidate metabolic markers with strong potential for early detection and characterize invasiveness of the disease and identify potential therapeutic target pathways.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This work highlights the power of combining untargeted metabolomics with machine learning to map the metabolic landscape of BLCA and to accelerate the development of precision diagnostics and future therapeutic strategies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s40170-026-00427-4","type":"journal-article","created":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T06:33:18Z","timestamp":1775025198000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Leveraging untargeted metabolomics in combination with machine learning to uncover novel insights into bladder cancer"],"prefix":"10.1186","volume":"14","author":[{"given":"Abu Hena Mostafa","family":"Kamal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasanta","family":"Putluri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanmay","family":"Gandhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandra Shekar R.","family":"Ambati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandra Sekhar","family":"Amara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karthik Reddy","family":"Kami Reddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meredith Lauren","family":"Spradlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amrit","family":"Koirala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachin B.","family":"Jorvekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra L.","family":"Grimm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dexue","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishna","family":"Parsawar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felice de","family":"Jong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Beecher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subrata","family":"Sen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seth P.","family":"Lerner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Minhaj","family":"Siddiqui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yair","family":"Lotan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Livia S.","family":"Eberlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arun","family":"Sreekumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristian","family":"Coarfa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nagireddy","family":"Putluri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,1]]},"reference":[{"issue":"7","key":"427_CR1","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/nrd.2016.32","volume":"15","author":"DS Wishart","year":"2016","unstructured":"Wishart DS. Emerging applications of metabolomics in drug discovery and precision medicine. Nat Rev Drug Discov. 2016;15(7):473\u201384.","journal-title":"Nat Rev Drug Discov"},{"issue":"4","key":"427_CR2","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/nrm3314","volume":"13","author":"GJ Patti","year":"2012","unstructured":"Patti GJ, Yanes O, Siuzdak G. Innovation: Metabolomics: the apogee of the omics trilogy. Nat Rev Mol Cell Biol. 2012;13(4):263\u201369.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"10","key":"427_CR3","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s11306-016-1094-6","volume":"12","author":"RD Beger","year":"2016","unstructured":"Beger RD, Dunn W, Schmidt MA, Gross SS, Kirwan JA, Cascante M, et al. Metabolomics enables precision medicine: \u201cA white paper, community Perspective\u201d. Metabolomics. 2016;12(10):149.","journal-title":"Metabolomics"},{"issue":"6","key":"427_CR4","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1002\/mas.21562","volume":"37","author":"L Cui","year":"2018","unstructured":"Cui L, Lu H, Lee YH. Challenges and emergent solutions for LC-MS\/MS based untargeted metabolomics in diseases. Mass Spectrom Rev. 2018;37(6):772\u201392.","journal-title":"Mass Spectrom Rev"},{"issue":"2","key":"427_CR5","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1021\/ac5025649","volume":"87","author":"HP Benton","year":"2015","unstructured":"Benton HP, Ivanisevic J, Mahieu NG, Kurczy ME, Johnson CH, Franco L, et al. Autonomous metabolomics for rapid metabolite identification in global profiling. Anal Chem. 2015;87(2):884\u201391.","journal-title":"Anal Chem"},{"issue":"15","key":"427_CR6","doi-asserted-by":"publisher","first-page":"7558","DOI":"10.1021\/ac501353n","volume":"86","author":"M Calderon-Santiago","year":"2014","unstructured":"Calderon-Santiago M, Priego-Capote F, Luque de Castro MD. Enhanced detection and identification in metabolomics by use of LC-MS\/MS untargeted analysis in combination with gas-phase fractionation. Anal Chem. 2014;86(15):7558\u201365.","journal-title":"Anal Chem"},{"issue":"6","key":"427_CR7","first-page":"394","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394\u2013424.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"427_CR8","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1038\/s41467-024-45132-2","volume":"15","author":"CS Amara","year":"2024","unstructured":"Amara CS, Kami Reddy KR, Yuntao Y, Chan YS, Piyarathna DWB, Dobrolecki LE, et al. The IL6\/JAK\/STAT3 signaling axis is a therapeutic vulnerability in SMARCB1-deficient bladder cancer. Nat Commun. 2024;15(1):1373.","journal-title":"Nat Commun"},{"issue":"1","key":"427_CR9","first-page":"10","volume":"75","author":"RL Siegel","year":"2025","unstructured":"Siegel RL, Kratzer TB, Giaquinto AN, Sung H, Jemal A. Cancer statistics, 2025. CA Cancer J Clin. 2025;75(1):10\u201345.","journal-title":"CA Cancer J Clin"},{"key":"427_CR10","unstructured":"Survival Rates for Bladder Cancer [https:\/\/www.cancer.org\/cancer\/types\/bladder-cancer\/detection-diagnosis-staging\/survival-rates.html]."},{"issue":"24","key":"427_CR11","doi-asserted-by":"publisher","first-page":"7376","DOI":"10.1158\/0008-5472.CAN-11-1154","volume":"71","author":"N Putluri","year":"2011","unstructured":"Putluri N, Shojaie A, Vasu VT, Vareed SK, Nalluri S, Putluri V, et al. Metabolomic profiling reveals potential markers and bioprocesses altered in bladder cancer progression. Cancer Res. 2011;71(24):7376\u201386.","journal-title":"Cancer Res"},{"key":"427_CR12","doi-asserted-by":"crossref","unstructured":"Kami Reddy KR, Piyarathna DWB, Park JH, Putluri V, Amara CS, Kamal AHM, et al. Mitochondrial reprogramming by activating OXPHOS via glutamine metabolism in African American patients with bladder cancer. JCI Insight. 2024;9(17).","DOI":"10.1172\/jci.insight.172336"},{"issue":"10061","key":"427_CR13","doi-asserted-by":"publisher","first-page":"2796","DOI":"10.1016\/S0140-6736(16)30512-8","volume":"388","author":"AM Kamat","year":"2016","unstructured":"Kamat AM, Hahn NM, Efstathiou JA, Lerner SP, Malmstrom PU, Choi W, et al. Bladder cancer. Lancet. 2016;388(10061):2796\u2013810.","journal-title":"Lancet"},{"issue":"7231","key":"427_CR14","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1038\/nature07762","volume":"457","author":"A Sreekumar","year":"2009","unstructured":"Sreekumar A, Poisson LM, Rajendiran TM, Khan AP, Cao Q, Yu J, et al. Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature. 2009;457(7231):910\u201314.","journal-title":"Nature"},{"issue":"40","key":"427_CR15","doi-asserted-by":"publisher","first-page":"6265","DOI":"10.1038\/s41388-019-0902-7","volume":"39","author":"V Vantaku","year":"2020","unstructured":"Vantaku V, Putluri V, Bader DA, Maity S, Ma J, Arnold JM, et al. Epigenetic loss of AOX1 expression via EZH2 leads to metabolic deregulations and promotes bladder cancer progression. Oncogene. 2020;39(40):6265\u201385.","journal-title":"Oncogene"},{"key":"427_CR16","doi-asserted-by":"crossref","unstructured":"Vantaku V, Dong J, Ambati CR, Perera D, Donepudi SR, Amara CS, et al. multi-omics integration anal robustly predicts high-grade patient survival identifies CPT1B Effect Fat Acid Metab Bladder Cancer. Clin Cancer Res. 2019;25(12):3689\u2013701.","DOI":"10.1158\/1078-0432.CCR-18-1515"},{"issue":"6","key":"427_CR17","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1002\/cncr.31890","volume":"125","author":"V Vantaku","year":"2019","unstructured":"Vantaku V, Donepudi SR, Piyarathna DWB, Amara CS, Ambati CR, Tang W, et al. Large-scale profiling of serum metabolites in African American and European American patients with bladder cancer reveals metabolic pathways associated with patient survival. Cancer. 2019;125(6):921\u201332.","journal-title":"Cancer"},{"issue":"4","key":"427_CR18","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1080\/14789450.2019.1583105","volume":"16","author":"CS Amara","year":"2019","unstructured":"Amara CS, Vantaku V, Lotan Y, Putluri N. Recent advances in the metabolomic study of bladder cancer. Expert Rev Proteomics. 2019;16(4):315\u201324.","journal-title":"Expert Rev Proteomics"},{"issue":"1","key":"427_CR19","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1186\/s12967-025-06258-z","volume":"23","author":"Y Li","year":"2025","unstructured":"Li Y, Yadollahi P, Essien FN, Putluri V, Ambati CSR, Kami Reddy KR, et al. Tobacco smoke exposure is a driver of altered oxidative stress response and immunity in head and neck cancer. J Transl Med. 2025;23(1):403.","journal-title":"J Transl Med"},{"issue":"1","key":"427_CR20","doi-asserted-by":"publisher","first-page":"4841","DOI":"10.1038\/s41598-024-55356-3","volume":"14","author":"B Cooper","year":"2024","unstructured":"Cooper B, Yang R. An assessment of AcquireX and Compound Discoverer software 3.3 for non-targeted metabolomics. Sci Rep. 2024;14(1):4841.","journal-title":"Sci Rep"},{"key":"427_CR21","doi-asserted-by":"crossref","unstructured":"Wishart DS, Feunang YD, Guo AC, Lo EJ, Marcu A, Grant JR, et al. DrugBank 5.0: a major update to the DrugBank database for 2018. Nucleic Acids Res. 2018;46(D1):D1074\u201382.","DOI":"10.1093\/nar\/gkx1037"},{"issue":"1","key":"427_CR22","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini Y, Hochberg Y. Controlling the false discovery Rate: a Practical and powerful approach to multiple testing. J R Stat Soc: Ser B (Methodological). 1995;57(1):289\u2013300.","journal-title":"J R Stat Soc: Ser B (Methodological)"},{"issue":"1","key":"427_CR23","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1002\/cam4.4933","volume":"12","author":"J Thaiparambil","year":"2023","unstructured":"Thaiparambil J, Dong J, Grimm SL, Perera D, Ambati CSR, Putluri V, et al. Integrative metabolomics and transcriptomics analysis reveals novel therapeutic vulnerabilities in lung cancer. Cancer Med. 2023;12(1):584\u201396.","journal-title":"Cancer Med"},{"key":"427_CR24","doi-asserted-by":"publisher","first-page":"216724","DOI":"10.1016\/j.canlet.2024.216724","volume":"587","author":"D Murthy","year":"2024","unstructured":"Murthy D, Dutta D, Attri KS, Samanta T, Yang S, Jung KH, et al. CD24 negativity reprograms mitochondrial metabolism to PPARalpha and NF-kappaB-driven fatty acid beta-oxidation in triple-negative breast cancer. Cancer Lett. 2024;587:216724.","journal-title":"Cancer Lett"},{"issue":"2","key":"427_CR25","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1021\/pr401106h","volume":"13","author":"AK Kaushik","year":"2014","unstructured":"Kaushik AK, Vareed SK, Basu S, Putluri V, Putluri N, Panzitt K, et al. Metabolomic profiling identifies biochemical pathways associated with castration-resistant prostate cancer. J Proteome Res. 2014;13(2):1088\u2013100.","journal-title":"J. Proteome Res"},{"key":"427_CR26","doi-asserted-by":"publisher","first-page":"1421030","DOI":"10.3389\/fmolb.2024.1421030","volume":"11","author":"V Kannan","year":"2024","unstructured":"Kannan V, Srimadh Bhagavatham SK, Dandamudi RB, Kunchala H, Challa S, Almansour AI, et al. Integrated clinical and metabolomic analysis identifies molecular signatures, biomarkers, and therapeutic targets in primary angle closure glaucoma. Front Mol Biosci. 2024;11:1421030.","journal-title":"Front Mol Biosci"},{"issue":"1","key":"427_CR27","doi-asserted-by":"publisher","first-page":"3764","DOI":"10.1038\/s41467-024-48106-6","volume":"15","author":"T Braun","year":"2024","unstructured":"Braun T, Feng R, Amir A, Levhar N, Shacham H, Mao R, et al. Diet-omics in the study of Urban and rural crohn disease evolution (SOURCE) cohort. Nat Commun. 2024;15(1):3764.","journal-title":"Nat Commun"},{"key":"427_CR28","doi-asserted-by":"crossref","unstructured":"Wishart DS, Guo A, Oler E, Wang F, Anjum A, Peters H, et al. HMDB 5.0: the Human metabolome database for 2022. Nucleic Acids Res. 2022;50(D1):D622\u201331.","DOI":"10.1093\/nar\/gkab1062"},{"key":"427_CR29","doi-asserted-by":"crossref","unstructured":"Wieder C, Frainay C, Poupin N, Rodriguez-Mier P, Vinson F, Cooke J, et al. Pathway analysis in metabolomics: recommendations for the use of over-representation analysis. PLoS Comput Biol. 2021;17(9):e1009105.","DOI":"10.1371\/journal.pcbi.1009105"},{"key":"427_CR30","doi-asserted-by":"crossref","unstructured":"Lu Y, Pang Z, Xia J. Comprehensive investigation of pathway enrichment methods for functional interpretation of LC-MS global metabolomics data. Brief Bioinform. 2023;24(1).","DOI":"10.1093\/bib\/bbac553"},{"key":"427_CR31","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.2147\/JHC.S474010","volume":"11","author":"H Powell","year":"2024","unstructured":"Powell H, Coarfa C, Ruiz-Echartea E, Grimm SL, Najjar O, Yu B, et al. Differences in prediagnostic serum metabolomic and lipidomic profiles between cirrhosis patients with and without incident hepatocellular carcinoma. J Hepatocell Carcinoma. 2024;11:1699\u2013712.","journal-title":"J Hepatocell Carcinoma"},{"key":"427_CR32","doi-asserted-by":"crossref","unstructured":"Kanehisa M, Furumichi M, Tanabe M, Sato Y, Morishima K. KEGG: new perspectives on genomes, pathways, diseases and drugs. Nucleic Acids Res. 2017;45(D1):D353\u201361.","DOI":"10.1093\/nar\/gkw1092"},{"key":"427_CR33","doi-asserted-by":"crossref","unstructured":"Croft D, O\u2019Kelly G, Wu G, Haw R, Gillespie M, Matthews L, et al. Reactome: a database of reactions, pathways and biological processes. Nucleic Acids Res. 2011;39(Database issue):D691\u2013697.","DOI":"10.1093\/nar\/gkq1018"},{"issue":"6","key":"427_CR34","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","volume":"1","author":"A Liberzon","year":"2015","unstructured":"Liberzon A, Birger C, Thorvaldsdottir H, Ghandi M, Mesirov JP, Tamayo P. The molecular signatures database (MSigDB) hallmark gene set collection. Cell Syst. 2015;1(6):417\u201325.","journal-title":"Cell Syst"},{"key":"427_CR35","doi-asserted-by":"crossref","unstructured":"Harris MA, Clark J, Ireland A, Lomax J, Ashburner M, Foulger R, et al. The Gene Ontology (GO) database and informatics resource. Nucleic Acids Res. 2004;32(Database issue):D258\u2013261.","DOI":"10.1093\/nar\/gkh036"},{"issue":"1","key":"427_CR36","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1023\/A:1010933404324","volume":"45","author":"L Breiman","year":"2001","unstructured":"Breiman L. Random forests. Mach Learn. 2001;45(1):5\u201332.","journal-title":"Mach Learn"},{"issue":"3","key":"427_CR37","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1023\/A:1022627411411","volume":"20","author":"C Cortes","year":"1995","unstructured":"Cortes C, Vapnik V. Support-vector networks. Mach Learn. 1995;20(3):273\u201397.","journal-title":"Mach Learn"},{"issue":"5","key":"427_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v028.i05","volume":"28","author":"M Kuhn","year":"2008","unstructured":"Kuhn M. Building predictive models in R using the caret package. J Stat Softw. 2008;28(5):1\u201326.","journal-title":"J Stat Softw"},{"key":"427_CR39","doi-asserted-by":"crossref","unstructured":"Molnar C, Casalicchio G. Bischl B: iml: an R package for Interpretable machine learning. J Educ Chang Open Source Softw. 2018;3(26).","DOI":"10.21105\/joss.00786"},{"issue":"1","key":"427_CR40","doi-asserted-by":"publisher","first-page":"6656","DOI":"10.1038\/s41467-022-34537-6","volume":"13","author":"Z Zhou","year":"2022","unstructured":"Zhou Z, Luo M, Zhang H, Yin Y, Cai Y, Zhu ZJ. Metabolite annotation from knowns to unknowns through knowledge-guided multi-layer metabolic networking. Nat Commun. 2022;13(1):6656.","journal-title":"Nat Commun"},{"key":"427_CR41","doi-asserted-by":"crossref","unstructured":"Reisdorph NA, Walmsley S, Reisdorph R. A Perspective and framework for developing sample type specific databases for LC\/MS-Based clinical metabolomics. Metabolites. 2019;10(1).","DOI":"10.3390\/metabo10010008"},{"key":"427_CR42","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.copbio.2018.07.010","volume":"55","author":"R Chaleckis","year":"2019","unstructured":"Chaleckis R, Meister I, Zhang P, Wheelock CE. Challenges, progress and promises of metabolite annotation for LC-MS-based metabolomics. Curr Opin Biotechnol. 2019;55:44\u201350.","journal-title":"Curr Opin Biotechnol"},{"issue":"11","key":"427_CR43","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1038\/sj.onc.1209377","volume":"25","author":"C Rodriguez-Antona","year":"2006","unstructured":"Rodriguez-Antona C. Ingelman-sundberg M: cytochrome P450 pharmacogenetics and cancer. Oncogene. 2006;25(11):1679\u201391.","journal-title":"Oncogene"},{"issue":"12","key":"427_CR44","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1038\/nrc2015","volume":"6","author":"DW Nebert","year":"2006","unstructured":"Nebert DW, Dalton TP. The role of cytochrome P450 enzymes in endogenous signalling pathways and environmental carcinogenesis. Nat Rev Cancer. 2006;6(12):947\u201360.","journal-title":"Nat Rev Cancer"},{"issue":"5","key":"427_CR45","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/nrd792","volume":"1","author":"FP Guengerich","year":"2002","unstructured":"Guengerich FP. Cytochrome P450 enzymes in the generation of commercial products. Nat Rev Drug Discov. 2002;1(5):359\u201366.","journal-title":"Nat Rev Drug Discov"},{"key":"427_CR46","doi-asserted-by":"publisher","first-page":"1377373","DOI":"10.3389\/fonc.2024.1377373","volume":"14","author":"K Mrowiec","year":"2024","unstructured":"Mrowiec K, Debik J, Jelonek K, Kurczyk A, Ponge L, Wilk A, et al. Profiling of serum metabolome of breast cancer: multi-cancer features discriminate between healthy women and patients with breast cancer. Front Oncol. 2024;14:1377373.","journal-title":"Front Oncol"},{"issue":"3","key":"427_CR47","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1615\/CritRevBiomedEng.2013007736","volume":"41","author":"AK Kosmides","year":"2013","unstructured":"Kosmides AK, Kamisoglu K, Calvano SE, Corbett SA, Androulakis IP. Metabolomic fingerprinting: challenges and opportunities. Crit Rev Biomed Eng. 2013;41(3):205\u201321.","journal-title":"Crit Rev Biomed Eng"},{"issue":"1","key":"427_CR48","doi-asserted-by":"publisher","first-page":"3763","DOI":"10.1038\/s41467-019-11738-0","volume":"10","author":"Z Xiao","year":"2019","unstructured":"Xiao Z, Dai Z, Locasale JW. Metabolic landscape of the tumor microenvironment at single cell resolution. Nat Commun. 2019;10(1):3763.","journal-title":"Nat Commun"},{"key":"427_CR49","doi-asserted-by":"crossref","unstructured":"Schiliro C, Firestein BL. Mechanisms of metabolic reprogramming in cancer Cells supporting Enhanced growth and proliferation. Cells. 2021;10(5).","DOI":"10.3390\/cells10051056"},{"issue":"1","key":"427_CR50","first-page":"1","volume":"11","author":"LM Phan","year":"2014","unstructured":"Phan LM, Yeung SC, Lee MH. Cancer metabolic reprogramming: importance, main features, and potentials for precise targeted anti-cancer therapies. Cancer Biol Med. 2014;11(1):1\u201319.","journal-title":"Cancer Biol Med"},{"issue":"1","key":"427_CR51","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.gendis.2016.12.001","volume":"4","author":"T Li","year":"2017","unstructured":"Li T, Deng P. Nuclear magnetic resonance technique in tumor metabolism. Genes Dis. 2017;4(1):28\u201336.","journal-title":"Genes Dis"},{"key":"427_CR52","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.jmr.2015.07.014","volume":"260","author":"GA Nagana Gowda","year":"2015","unstructured":"Nagana Gowda GA, Raftery D. Can NMR solve some significant challenges in metabolomics? J Magn Reson. 2015;260:144\u201360.","journal-title":"J Magn Reson"},{"issue":"1","key":"427_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1146\/annurev-anchem-061020-015544","volume":"16","author":"ME King","year":"2023","unstructured":"King ME, Lin M, Spradlin M, Eberlin LS. Advances and Emerging Medical applications of direct mass spectrometry technologies for tissue analysis. Annu Rev Anal Chem (Palo Alto Calif). 2023;16(1):1\u201325.","journal-title":"Annu Rev Anal Chem (Palo Alto Calif)"},{"key":"427_CR54","doi-asserted-by":"crossref","unstructured":"Godfrey TM, Shanneik Y, Zhang W, Tran T, Verbeeck N, Patterson NH, et al. Integrating ambient ionization mass spectrometry imaging and spatial transcriptomics on the same cancer tissues to identify RNA-Metabolite correlations. Angew Chem Int Ed Engl. 2025;e202502028.","DOI":"10.1101\/2024.12.20.626670"},{"key":"427_CR55","doi-asserted-by":"crossref","unstructured":"Gatmaitan AN, Weaver K, Badal SP, Bird HE, Huhn A, Hussey C, et al. Development and application of the modular MasSpec Pen System for clinical opioid screening. Anal Chem 2025.","DOI":"10.1021\/acs.analchem.5c00558"},{"key":"427_CR56","doi-asserted-by":"crossref","unstructured":"Garza KY, King ME, Nagi C, DeHoog RJ, Zhang J, Sans M, et al. Intraoperative Evaluation of breast tissues during breast cancer operations using the MasSpec Pen. JAMA Netw Open. 2024;7(3):e242684.","DOI":"10.1001\/jamanetworkopen.2024.2684"},{"issue":"3","key":"427_CR57","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s11306-010-0254-3","volume":"7","author":"MM Koek","year":"2011","unstructured":"Koek MM, Jellema RH, van der Greef J, Tas AC, Hankemeier T. Quantitative metabolomics based on gas chromatography mass spectrometry: status and perspectives. Metabolomics. 2011;7(3):307\u201328.","journal-title":"Metabolomics"},{"key":"427_CR58","doi-asserted-by":"crossref","unstructured":"Fiehn O. Metabolomics by gas chromatography-mass spectrometry: combined targeted and untargeted profiling. Curr Protoc Mol Biol. 2016;114: 30 34 31\u201330 34 32.","DOI":"10.1002\/0471142727.mb3004s114"},{"issue":"28","key":"427_CR59","doi-asserted-by":"publisher","first-page":"10655","DOI":"10.1021\/acs.analchem.3c01155","volume":"95","author":"Y He","year":"2023","unstructured":"He Y, Shishkova E, Peters-Clarke TM, Brademan DR, Westphall MS, Bergen D, et al. Evaluation of the Orbitrap ascend Tribrid mass spectrometer for shotgun Proteomics. Anal Chem. 2023;95(28):10655\u201363.","journal-title":"Anal Chem"},{"issue":"6","key":"427_CR60","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1016\/j.juro.2016.01.039","volume":"195","author":"von Rundstedt Fc","year":"2016","unstructured":"von Rundstedt Fc, Rajapakshe K, Ma J, Arnold JM, Gohlke J, Putluri V, et al. Integrative pathway analysis of metabolic signature in bladder cancer: a linkage to the cancer genome atlas project and prediction of survival. J Urol. 2016;195(6):1911\u201319.","journal-title":"J Urol"},{"issue":"3","key":"427_CR61","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1097\/CCO.0000000000001137","volume":"37","author":"S Razavi","year":"2025","unstructured":"Razavi S, Khan A, Fu DX, Mayer D, McConkey D, Putluri N, et al. Metabolic landscape in bladder cancer. Curr. Opin. Oncol. 2025;37(3):259\u201366.","journal-title":"Curr. Opin. Oncol"},{"issue":"11","key":"427_CR62","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1093\/carcin\/bgz128","volume":"40","author":"V Vantaku","year":"2019","unstructured":"Vantaku V, Amara CS, Piyarathna DWB, Donepudi SR, Ambati CR, Putluri V, et al. DNA methylation patterns in bladder tumors of African American patients point to distinct alterations in xenobiotic metabolism. Carcinogenesis. 2019;40(11):1332\u201340.","journal-title":"Carcinogenesis"},{"issue":"1","key":"427_CR63","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1038\/s41467-024-46043-y","volume":"15","author":"Y Chen","year":"2024","unstructured":"Chen Y, Wang B, Zhao Y, Shao X, Wang M, Ma F, et al. Metabolomic machine learning predictor for diagnosis and prognosis of gastric cancer. Nat Commun. 2024;15(1):1657.","journal-title":"Nat Commun"},{"key":"427_CR64","doi-asserted-by":"crossref","unstructured":"Liebal UW, Phan ANT, Sudhakar M, Raman K, Blank LM. Machine learning applications for mass spectrometry-based metabolomics. Metabolites. 2020;10(6).","DOI":"10.3390\/metabo10060243"},{"issue":"1","key":"427_CR65","doi-asserted-by":"publisher","first-page":"25755","DOI":"10.1038\/s41598-024-77352-3","volume":"14","author":"X Zhou","year":"2024","unstructured":"Zhou X, Sun X, Zhao H, Xie F, Li B, Zhang J. Biomarker identification and risk assessment of cardiovascular disease based on untargeted metabolomics and machine learning. Sci Rep. 2024;14(1):25755.","journal-title":"Sci Rep"},{"key":"427_CR66","doi-asserted-by":"crossref","unstructured":"Moskaleva NE, Shestakova KM, Kukharenko AV, Markin PA, Kozhevnikova MV, Korobkova EO, et al. Target metabolome profiling-based machine learning as a diagnostic approach for cardiovascular diseases in adults. Metabolites. 2022;12(12).","DOI":"10.3390\/metabo12121185"},{"issue":"1","key":"427_CR67","doi-asserted-by":"publisher","first-page":"3556","DOI":"10.1038\/s41467-020-17347-6","volume":"11","author":"L Huang","year":"2020","unstructured":"Huang L, Wang L, Hu X, Chen S, Tao Y, Su H, et al. Machine learning of serum metabolic patterns encodes early-stage lung adenocarcinoma. Nat Commun. 2020;11(1):3556.","journal-title":"Nat Commun"},{"issue":"4","key":"427_CR68","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1097\/MOG.0000000000000945","volume":"39","author":"F Zulqarnain","year":"2023","unstructured":"Zulqarnain F, Rhoads SF, Syed S. Machine and deep learning in inflammatory bowel disease. Curr Opin Gastroenterol. 2023;39(4):294\u2013300.","journal-title":"Curr Opin Gastroenterol"},{"issue":"1","key":"427_CR69","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1186\/s12911-019-1004-8","volume":"19","author":"S Uddin","year":"2019","unstructured":"Uddin S, Khan A, Hossain ME, Moni MA. Comparing different supervised machine learning algorithms for disease prediction. BMC Med Inf Decis Mak. 2019;19(1):281.","journal-title":"BMC Med Inf Decis Mak"},{"issue":"6","key":"427_CR70","doi-asserted-by":"publisher","first-page":"100103","DOI":"10.1016\/j.crmeth.2021.100103","volume":"1","author":"HD Summers","year":"2021","unstructured":"Summers HD. Practical machine learning for disease diagnosis. Cell Rep Methods. 2021;1(6):100103.","journal-title":"Cell Rep Methods"},{"key":"427_CR71","doi-asserted-by":"publisher","first-page":"104737","DOI":"10.1016\/j.jprot.2022.104737","volume":"270","author":"Q Chang","year":"2023","unstructured":"Chang Q, Chen P, Yin J, Liang G, Dai Y, Guan Y, et al. Discovery and validation of bladder cancer related excreted nucleosides biomarkers by dilution approach in cell culture supernatant and urine using UHPLC-MS\/MS. J Proteomics. 2023;270:104737.","journal-title":"J Proteomics"},{"issue":"4","key":"427_CR72","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1007\/s10147-008-0811-1","volume":"13","author":"H Enokida","year":"2008","unstructured":"Enokida H, Nakagawa M. Epigenetics in bladder cancer. Int J Clin Oncol. 2008;13(4):298\u2013307.","journal-title":"Int J Clin Oncol"},{"issue":"1","key":"427_CR73","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s13045-022-01285-5","volume":"15","author":"Y Luo","year":"2022","unstructured":"Luo Y, Yao Y, Wu P, Zi X, Sun N, He J. The potential role of N(7)-methylguanosine (m7G) in cancer. J Hematol Oncol. 2022;15(1):63.","journal-title":"J Hematol Oncol"},{"issue":"2","key":"427_CR74","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1158\/1078-0432.CCR-08-1059","volume":"15","author":"JL Spratlin","year":"2009","unstructured":"Spratlin JL, Serkova NJ, Eckhardt SG. Clinical applications of metabolomics in oncology: a review. Clin Cancer Res. 2009;15(2):431\u201340.","journal-title":"Clin Cancer Res"},{"issue":"3","key":"427_CR75","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.bbamcr.2004.12.001","volume":"1743","author":"Z Song","year":"2005","unstructured":"Song Z, Uriarte S, Sahoo R, Chen T, Barve S, Hill D, et al. S-adenosylmethionine (SAMe) modulates interleukin-10 and interleukin-6, but not TNF, production via the adenosine (A2) receptor. Biochim Biophys Acta. 2005;1743(3):205\u201313.","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"427_CR76","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/s42003-022-03280-5","volume":"5","author":"K Fukumoto","year":"2022","unstructured":"Fukumoto K, Ito K, Saer B, Taylor G, Ye S, Yamano M, et al. Excess S-adenosylmethionine inhibits methylation via catabolism to adenine. Commun Biol. 2022;5(1):313.","journal-title":"Commun Biol"},{"key":"427_CR77","doi-asserted-by":"crossref","unstructured":"Fernandez-Ramos D, Lopitz-Otsoa F, Lu SC, Mato JM. S-Adenosylmethionine: a multifaceted regulator in cancer pathogenesis and therapy. Cancers (Basel). 2025;17(3).","DOI":"10.3390\/cancers17030535"},{"key":"427_CR78","doi-asserted-by":"crossref","unstructured":"Loras A, Segovia C, Ruiz-Cerda JL. Epigenomic and Metabolomic Integration reveals dynamic metabolic regulation in bladder cancer. Cancers (Basel). 2021;13(11).","DOI":"10.3390\/cancers13112719"},{"issue":"1","key":"427_CR79","doi-asserted-by":"publisher","first-page":"3477","DOI":"10.1038\/s41598-018-21932-7","volume":"8","author":"L Erichsen","year":"2018","unstructured":"Erichsen L, Ghanjati F, Beermann A, Poyet C, Hermanns T, Schulz WA, et al. Aberrant methylated key genes of methyl group metabolism within the molecular etiology of urothelial carcinogenesis. Sci Rep. 2018;8(1):3477.","journal-title":"Sci Rep"},{"issue":"1","key":"427_CR80","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s12672-023-00843-8","volume":"14","author":"X Zhou","year":"2023","unstructured":"Zhou X, Zhu H, Luo C, Yan Z, Zheng G, Zou X, et al. The role of RNA modification in urological cancers: mechanisms and clinical potential. Discov Oncol. 2023;14(1):235.","journal-title":"Discov Oncol"},{"key":"427_CR81","doi-asserted-by":"crossref","unstructured":"Wu H, Chen S, Li X, Li Y, Shi H, Qing Y, et al. RNA modifications in cancer. MedComm (2020). 2025;6(1):e70042.","DOI":"10.1002\/mco2.70042"},{"key":"427_CR82","doi-asserted-by":"publisher","first-page":"1246069","DOI":"10.1155\/2018\/1246069","volume":"2018","author":"E Richard","year":"2018","unstructured":"Richard E, Gallego-Villar L, Rivera-Barahona A, Oyarzabal A, Perez B, Rodriguez-Pombo P, et al. Altered redox homeostasis in Branched-Chain amino acid disorders, organic acidurias, and homocystinuria. Oxid Med Cell Longev. 2018;2018:1246069.","journal-title":"Oxid Med Cell Longev"},{"issue":"2","key":"427_CR83","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.ccell.2019.12.011","volume":"37","author":"S Sivanand","year":"2020","unstructured":"Sivanand S, Vander Heiden MG. Emerging roles for Branched-Chain amino acid metabolism in cancer. Cancer Cell. 2020;37(2):147\u201356.","journal-title":"Cancer Cell"},{"issue":"7655","key":"427_CR84","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1038\/nature22314","volume":"545","author":"A Hattori","year":"2017","unstructured":"Hattori A, Tsunoda M, Konuma T, Kobayashi M, Nagy T, Glushka J, et al. Cancer progression by reprogrammed BCAA metabolism in myeloid leukaemia. Nature. 2017;545(7655):500\u201304.","journal-title":"Nature"},{"key":"427_CR85","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.3389\/fimmu.2018.01697","volume":"9","author":"J Yin","year":"2018","unstructured":"Yin J, Ren W, Huang X, Deng J, Li T, Yin Y. Potential mechanisms connecting purine metabolism and cancer Therapy. Front Immunol. 2018;9:1697.","journal-title":"Front. Immunol"},{"issue":"14","key":"427_CR86","doi-asserted-by":"publisher","first-page":"3602","DOI":"10.1016\/j.cell.2024.05.011","volume":"187","author":"DH Tran","year":"2024","unstructured":"Tran DH, Kim D, Kesavan R, Brown H, Dey T, Soflaee MH, et al. De Novo and salvage purine synthesis pathways across tissues and tumors. Cell. 2024;187(14):3602\u201318 e 3620.","journal-title":"Cell"},{"issue":"1","key":"427_CR87","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/s41392-021-00553-z","volume":"6","author":"Z Huang","year":"2021","unstructured":"Huang Z, Xie N, Illes P, Di Virgilio F, Ulrich H, Semyanov A, et al. From purines to purinergic signalling: molecular functions and human diseases. Signal Transduct Target Ther. 2021;6(1):162.","journal-title":"Signal Transduct Target Ther"},{"issue":"20","key":"427_CR88","doi-asserted-by":"publisher","first-page":"4345","DOI":"10.1158\/1078-0432.CCR-25-1667","volume":"31","author":"J Yu","year":"2025","unstructured":"Yu J, Jin C, Su C, Moon D, Sun MA, Zhang H, et al. Resilience and vulnerabilities of tumor cells under purine shortage stress. Clin Cancer Res. 2025;31(20):4345\u201360.","journal-title":"Clin Cancer Res"},{"issue":"6","key":"427_CR89","doi-asserted-by":"publisher","first-page":"152409","DOI":"10.1016\/j.seminoncol.2025.152409","volume":"52","author":"Z Lu","year":"2025","unstructured":"Lu Z, Li J, Liu Y, Li H, Sun Y, Geng R, et al. Purine metabolism in tumorigenesis and its clinical implications. Semin Oncol. 2025;52(6):152409.","journal-title":"Semin Oncol"},{"issue":"8","key":"427_CR90","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1038\/s41556-022-00965-1","volume":"24","author":"FF Diehl","year":"2022","unstructured":"Diehl FF, Miettinen TP, Elbashir R, Nabel CS, Darnell AM, Do BT, et al. Nucleotide imbalance decouples cell growth from cell proliferation. Nat Cell Biol. 2022;24(8):1252\u201364.","journal-title":"Nat Cell Biol"},{"key":"427_CR91","doi-asserted-by":"publisher","first-page":"90","DOI":"10.3389\/fcell.2018.00090","volume":"6","author":"A Rosenzweig","year":"2018","unstructured":"Rosenzweig A, Blenis J, Gomes AP. Beyond the Warburg Effect: how Do cancer cells regulate One-carbon metabolism? Front. Cell Dev. Biol. 2018;6:90.","journal-title":"Front. Cell Dev. Biol"}],"container-title":["Cancer &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40170-026-00427-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40170-026-00427-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40170-026-00427-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T21:17:58Z","timestamp":1781644678000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40170-026-00427-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,1]]},"references-count":91,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["427"],"URL":"https:\/\/doi.org\/10.1186\/s40170-026-00427-4","relation":{},"ISSN":["2049-3002"],"issn-type":[{"value":"2049-3002","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,1]]},"assertion":[{"value":"17 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All human tissue samples were collected from tumor bank from UTSW, UMB and de-identified samples were analysed under protocols approved by the Institutional Review Board: protocol H-35808 (BCM) from UTSW, UMB. De-identified samples from CHTN were obtained by Dr. Eberlin (under MTA) and trasnsfered to Dr. Putluri lab (under MTA) for metabolomics analysis.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All the authors have read and approved the submission of the current version of the manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"AS is Scientific Advisor to Karkinos Health Care Pvt Ltd., India, and is an unpaid visiting faculty to Sri Sathya Sai Institute for Higher Learning, India.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8"}}